Genomic Outcomes of Metformin

NCT02986659 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Mild Cognitive Impairment
Obesity, Abdominal
Hypertension

Interventions

DRUG: Metformin
DRUG: Placebo

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]